Credit: Tushar Mehta / Android Authority
TL;DR
- Samsung is partnering with the Massachusetts General Hospital (MGH) to investigate the effects of Ozempic and other GLP-1 RA drugs.
- Researchers will use body composition and other features of the Galaxy Watch 8 to study trends in rapid muscle loss during treatment.
- The control group will also receive personalized health insights for controlled weight loss.
The Samsung Galaxy Watch offers a wider range of health metrics than most rivals in the Wear OS space. That’s one of the reasons why I also prefer the Galaxy Watch over the Pixel Watch. And Samsung now plans to use those markers to help prevent side effects in patients using Ozempic and other GLP-1 RA medications for weight loss.
Don’t want to miss the best from Android Authority?
​Â
